Bio

Overseeing commercial and early stage integrated global translational access function to transform rare diseases through gene therapies. • 20+ years global commercialization experience including: market access; global pricing; drug development; BD&L; real world evidence; private equity; consultancy; and healthcare systems. • Builds deliberate diverse teams and alliances in complex business environments to expedite translational science into commercial execution.